Mirum Pharmaceuticals, Inc. (MIRM)
96.74
+0.44
(+0.45%)
USD |
NASDAQ |
Aug 24, 16:00
96.74
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Shareholders Equity (Quarterly) : -10.42M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.42M |
| March 31, 2026 | 242.49M |
| December 31, 2025 | 314.69M |
| September 30, 2025 | 292.05M |
| June 30, 2025 | 255.16M |
| March 31, 2025 | 233.26M |
| December 31, 2024 | 225.64M |
| September 30, 2024 | 232.02M |
| June 30, 2024 | 228.99M |
| March 31, 2024 | 234.60M |
| December 31, 2023 | 248.67M |
| September 30, 2023 | 269.08M |
| June 30, 2023 | 78.61M |
| March 31, 2023 | 141.15M |
| December 31, 2022 | 142.04M |
| Date | Value |
|---|---|
| September 30, 2022 | 169.30M |
| June 30, 2022 | 110.69M |
| March 31, 2022 | 108.93M |
| December 31, 2021 | 120.21M |
| September 30, 2021 | 56.40M |
| June 30, 2021 | 95.74M |
| March 31, 2021 | 133.88M |
| December 31, 2020 | 172.10M |
| September 30, 2020 | 120.26M |
| June 30, 2020 | 136.21M |
| March 31, 2020 | 156.12M |
| December 31, 2019 | 130.35M |
| September 30, 2019 | 146.20M |
| June 30, 2019 | 91.88M |
| March 31, 2019 | 43.79M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Incyte Corp. | 6.344B |
| Insmed, Inc. | 757.49M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| BioMarin Pharmaceutical, Inc. | 6.322B |
| Ionis Pharmaceuticals, Inc. | 439.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.045B |
| Total Liabilities (Quarterly) | 1.055B |
| Debt to Equity Ratio | -73.21 |
| Current Ratio | 2.856 |
| Net Debt Paydown Yield | -1.18% |